We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

7180:TSEKyushu Financial Group, Inc. Analysis

Data as of 2026-03-15 - not real-time

¥1,173.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kyushu Financial Group is trading at ¥1,173, comfortably above its 20‑day (¥1,256) and 50‑day (¥1,197) moving averages but still above the 200‑day level (¥930), indicating a mixed technical picture where the longer‑term trend remains bullish despite short‑term weakness. The MACD histogram is negative and the RSI sits at 44, suggesting modest downside pressure, while volatility is elevated at roughly 55% and the max drawdown has reached 31%, flagging higher price swings.
Fundamentally, the bank delivers solid earnings growth – nine‑month net profit rose to ¥30.97 bn from ¥20.93 bn year‑over‑year – and enjoys a healthy operating margin of 27% with a dividend yield of 2.22% supported by a modest 28% payout ratio. Valuation metrics are attractive, with a PE of 13.9 versus the industry average of 16.4 and a PB of 0.66, though analysts’ target price of ¥1,075 suggests the market may be pricing in some near‑term correction. Overall, the stock offers a blend of value and modest growth, underpinned by strong cash balances and a stable dividend, but investors should be mindful of short‑term technical weakness and elevated volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram and RSI near neutral
  • Price trading below 20‑day and 50‑day SMAs
  • Proximity to support level at ¥1,110

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of ~9.7% YoY and improving earnings
  • Attractive valuation (PE below industry, PB <1)
  • Sustainable dividend yield of 2.22% with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong net cash position outweighing total debt
  • Stable dividend policy and low beta (0.74) reducing market risk
  • Consistent profitability and moderate ROE indicating steady returns

Key Metrics & Analysis

Financial Health

Revenue Growth9.70%
Profit Margin17.65%
P/E Ratio13.9
ROE5.50%
ROA0.29%
P/B Ratio0.7
Industry P/E16.4

Technical Analysis

TrendBullish
RSI44.4
Support¥1,110.00
Resistance¥1,377.50
MA 20¥1,256.45
MA 50¥1,196.67
MA 200¥929.86
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Target Price¥1,075.00
Upside/Downside-8.35%
GradeFair
TypeBlend
Dividend Yield2.22%

Risk Assessment

Beta0.74
Volatility55.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.